Dr. Gordon Keller, Director, McEwen Centre for Regenerative Medicine
Stem Cells - You can't live without them! Hear how Scientists are harnessing their power to treat everything from A-Z.
October 25th, 1:00-3:00 pm
Dr. Gordon Keller, Director, McEwen Centre for Regenerative Medicine will explain the most recent updates and impact of Stem Cell Research in Canada and discuss the breakthroughs and successful application to the big three diseases - Cancer, Diabetes and Heart Disease.
Gordon Keller is the Director of the McEwen Centre for Regenerative Medicine which was established in 2003. It is a world renowned centre for stem cell biology and regenerative medicine and a world class stem cell research facility. Keller’s is the first lab to successfully differentiate human embryonic stem (ES) cells into cardiac lineages. This technology has been successfully applied to human iPS cells and will be made available to create patient specific cardiac cell lines. As well as being the director of the McEwen Center for regenerative medicine he is also a Professor at the University of Toronto in the Department of Medical Biophysics. Keller also holds the position of Senior Scientist of the Ontario Cancer Institute in Toronto, ON Canada. He received his PhD at the University of Alberta in Immunology. Keller’s areas of research include lineage specific differentiation of ES cells in culture, development of the hematopoietic, vascular, and cardiac lineages from ES cells, commitment of ES cells to endoderm-derived lineages, and growth and differentiation of human embryonic stem cells. Dr. Keller is a key collaborator with many scientists and research teams across Canada and internationally. Current collaborations include those with Dr. Husain at UHN in Toronto, in the characterization of ES cell-derived cardiomyocytes and collaboration with Dr. Sherman from Columbia University, NY, in the analysis of the functional potential of human ES cell-derived cardiomyocytes in a large animal model. Dr. Keller also has several current on-going sources of grant funding from NIH and CIHR. Keller has contributed to 101 publications and holds extensive experience in collaborative research.